New Frontiers in Vaccine Development
Webinar

New Frontiers in Vaccine Development

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

Share

 LIVE Symposium

Tuesday, February 18, 2025
10:00 AM - 1:00 PM ET

Despite its long history, vaccination remains an effective means of reducing infectious disease susceptibility and transmission. As bacterial, viral, fungal, and protozoan pathogens continue to threaten the lives of people around the globe, scientists must design the next generation of vaccines.

In this symposium brought to you by The Scientist, researchers will discuss the current advancements in vaccine research and development for both emerging and common pathogens.

Symposium program

10:00 AM – Introduction

10:10 AM- Intranasal Vaccine for Lyme Disease

Maria Gomes-Solecki, DVM

10:45 AM – Fungal Vaccines: Advances and Challenges

Stuart Levitz, MD

11:15 AM – Development of a Next-Generation Adjuvanted Pertussis Vaccine

Lisa Morici, PhD

11:45 AM - Developing Next-Generation Influenza Vaccines

Ted Ross, PhD

12:15 PM - Open panel Q&A session
Charlene Lancaster from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.


Maria

Maria Gomes-Solecki, DVM
Professor
Departments of Microbiology, Immunology and Biochemistry, and Pharmaceutical Sciences
University of Tennessee Health Sciences Center

Stuart

Stuart Levitz, MD
Professor 
Departments of Medicine and Microbiology
University of Massachusetts (UMass) Chan Medical School
Attending Physician 
UMass Memorial Medical Center

Lisa

Lisa Morici, PhD
Professor 
Department of Microbiology and Immunology
Tulane University School of Medicine 

Ted Ross

Ted Ross, PhD
Global Director of Vaccine Development
Cleveland Clinic 


Top Image Credit:

New Frontiers in Vaccine Development

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies